Objective : The aim of this study was to document the natural course of asymptomatic adult moyamoya disease (MMD) and the factors related to disease progression to aid in treatment decisions.
INTRODUCTION
Moyamoya disease (MMD), characterized by progressive stenosis or occlusion of the bilateral intracranial internal carotid arteries, is associated with abnormal vascular networks at the base of the brain, termed the "moyamoya" vessels. 13 Family history of stroke 14 9 5
The number of cases for each characteristic is reported, unless noted otherwise. MRI = magnetic resonance imaging; SPECT = single photon emission computed tomography; MMD = moyamoya disease The prevalence of asymptomatic adult MMD has recently increased due to development of noninvasive diagnostic techniques and the increase in regular medical checkups. 11) Given the lack of guidance regarding treatment in these patients, the aim of this study was to document the natural course of asymptomatic adult MMD to aid in treatment decisions. Cerebral perfusion was measured in 41 patients using 99mTc-hexamethylpropylene amine oxime single photon emission computed tomography (SPECT), xenon computed tomography (CT), or positron emission tomography (PET), and cerebral reserve capacity was assessed after an intravenous injection of acetazolamide.
MATERIALS AND METHODS
Cerebral perfusion and reserve capacity images were interpreted as normal or decreased status, respectively, by the same competent professor of nuclear medicine.
Analysis of the relationships between disease progression and associated factors was performed using χ2 tests. The progression free survival rate was estimated by Kaplan-Meier analysis. The significance of the differences was assessed using the log-rank test.
IBM SPSS V. 21 (IBM Corp., Armonk, NY, United
States) was used in performance of statistical analyses. Table 1 .
RESULTS

Characteristics
Disease progression
According to the initial MRIs, 12 patients (28.6%) had old lacunar infarcts or microbleeding without symptoms. Reduced cerebrovascular reserve capacity (CVRC) was detected in the initial SPECT in 15 patients (23 hemispheres, 30.7%) ( Table 2 ). Disease progression was divided according to two categories: symptomatic progression, in which any neurological symptom developed, and asymptomatic radiographic progression, in which abnormal findings were detected in a follow-up radiological evaluation. Symptomatic is frequently referred to as "clinical progression" in other reports.
11)
Of the 42 patients and 75 hemispheres, there were 12 patients (28.6%) and 13 hemispheres (17.3%) with either category of disease progression. There were no relationships with sex, diabetes, hypertension, thyroid disease, family history of MMD, or family history of stroke. However, the initial CVRC was reduced in six patients (14.3%) and seven hemispheres (9.3%) in the patients with disease progression (Table 2) . Symptomatic progression (hemorrhagic or ischemic stroke) occurred in four patients, all women. The mean ± SD duration from MMD diagnosis to event occurrence was 20.8 ± 15.7 months (range, 7.6-41.1 months).
Reduced CVRC was observed in the initial SPECT for all four patients. Three patients experienced hemorrhagic stroke and basal ganglia intracerebral hemorrhage.
Two patients underwent decompressive craniectomy and removal of a hematoma due to a large amount of hemorrhage. The other patient received conservative In general, child MMD is considered to be progressive while adult MMD is relatively stable. 15) However, the current results and those of a previous study that reported disease progression in 15 of 120 adult patients (12.5%) suggest otherwise. 9) Further, higher rate of hemorrhagic stroke in adult MMD than that in children has been well documented.
3)13) There are differences in disease presentation and features between adults and children with moyamoya. 13) In addition, in children, disease diagnosis can be delayed and symptoms classified inaccurately owing to an inability to communicate.
5)
Suzuki and Takaku proposed an angiographic staging system for MMD. 15) However, the stages are not correlated with disease severity. Instead, CVRC has been known to be more effective for monitoring the progression of the disease; the patients are often in a chronic state of cerebral vasodilation, and maintenance of cerebral blood flow is necessary. 4) Therefore,
we evaluated the CVRC of the patients. Despite a lack of differences in the majority of factors between patients with and without disease progression, a relationship was observed with CVRC; decreased CVRC was evident with more progressed disease ( Table 2 ).
This was supported by the results of the Kaplan-Meier cumulative event-free survival analysis, in which a significant difference was observed between patients with progressive disease and a reduced initial CVRC and those with progressive disease and a normal initial CVRC (Fig. 1) . This difference was also evident in patients with symptomatic progression (Fig. 2) . Based on these results, CVRC may be an important indicator for patients with asymptomatic MMD, and closer observation or early revascularization surgery may be necessary in patients with reduced CVRC.
In our institute, symptomatic progression is an important indication for revascularization surgery in MMD patients. However, in this study, none of the However, in this report, stroke rate was 0%, but in our study, three patients (3/42, 7.1%) had stroke during the follow-up period. 6) This study has certain limitations. A retrospective review of medical records was used for collection of patient data. In addition, the sample size was small; however, MMD itself, particularly in the asymptomatic state, is very rare. Therefore, we plan to conduct future multi-center studies to guide treatment in adult, asymptomatic adult MMD patients.
CONCLUSION
The aim of this study was to document the disease course and factors related to disease progression in adults with asymptomatic MMD. Based on our results and those of previous studies, we conclude that asymptomatic adult MMD can no longer be considered a permanent stable disease. Therefore, close observation with regular brain imaging study is required for asymptomatic adult MMD patients, particularly patients with reduced CVRC.
